Partner Content Partner Content 1 week to SMi’s Superbugs & Superdrugs - REMOTE ACCESS ONLY 1 week to Superbugs & Superdrugs - REMOTE ACCESS ONLY
Partner Content Partner Content Interview with Martin Everett speaker at SMi’s Superbugs & S... Interview with Martin Everett speaker at Superbugs
Partner Content Partner Content Exclusive Interview with Martin Everett, CSO, Antabio, speak... Exclusive Interview with Martin Everett
Partner Content Partner Content Combioxin Speaking at SMi's 22nd Annual Superbugs & Superdru... Combioxin Speaking at SMi's 22nd Annual Superbugs
Partner Content Partner Content SMi’s 22nd Annual Superbugs & Superdrugs Conference 2020 – S... SMi’s 22nd Annual Superbugs & Superdrugs Conference
Partner Content Partner Content Genentech develop Antibiotic with potential to lead to new c... Superbugs & Superdrugs 2019
News Lilly grabs first-ever FDA nod for a sleep apnoea drug Lilly's Zepbound has become the first drug approved by the FDA for obese patients with obstructive sleep apnoea, which affects millions in the US.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
